Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis

Neurology

Volumn 86, Issue 5, 2016, Pages 410-417

  Roostaei, Tina ^a,b,d,e   Sadaghiani, Shokufeh ^a,b   Park, Min Tae M ^f,g   Mashhadi, Rahil ^c   Nazeri, Aria ^a   Noshad, Sina ^a   Salehi, Mohammad Javad ^h   Naghibzadeh, Maryam ^a,b   Moghadasi, Abdorreza Naser ^a,b   Owji, Mahsa ^a   Doosti, Rozita ^a   Taheri, Amir Pejman Hashemi ^b   Rad, Ali Shakouri ^b   Azimi, Amirreza ^a,i   Chakravarty, M Mallar ^f,j   Voineskos, Aristotle N ^d,e   Nazeri, Arash ^a,b,d,e   Sahraian, Mohammad Ali ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^g WESTERN UNIVERSITY   (Canada)

^h SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

ⁱ THOMAS JEFFERSON UNIVERSITY   (United States)

^j MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHANNEL NAV1.8; SCN10A PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BRAIN SIZE; CEREBELLAR DYSFUNCTION; CEREBELLAR VOLUMETRY; CEREBELLUM ATROPHY; CEREBELLUM DISEASE; CHANNELOPATHY; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS FUNCTIONAL COMPOSITE; NEUROLOGIC DISEASE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PACED AUDITORY SERIAL ADDITION TEST; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; THALAMUS; VOLUMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER; ADOLESCENT; CEREBELLAR DISEASES; CHANNELOPATHIES; GENETIC VARIATION; GENETICS; IRAN; LONGITUDINAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; YOUNG ADULT;

ADOLESCENT; ADULT; CEREBELLAR DISEASES; CHANNELOPATHIES; FEMALE; GENETIC VARIATION; HUMANS; IRAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; PREDICTIVE VALUE OF TESTS; YOUNG ADULT;

EID: 84957548786     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002326     Document Type: Article

References (39)

1. Thompson AJ, Toosy AT, Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 2010;9:1182-1199.
2. Waxman SG. Cerebellar dysfunction in multiple sclerosis: evidence for an acquired channelopathy. Prog Brain Res 2005;148:353-365.
3. Matthews W, Compston A, Allen I, Martyn C. McAlpine's Multiple Sclerosis. New York: Churchill Livingstone; 1991.
4. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-1231.
5. Shields SD, Cheng X, Gasser A, et al. A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis. Ann Neurol 2012;71:186-194.
6. Black JA, Dib-Hajj S, Baker D, Newcombe J, Cuzner ML, Waxman SG. Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci USA 2000;97:11598-11602.
7. V1.8 in Purkinje neurons in experimental autoimmune encephalomyelitis. Neurosci Lett 2004;369:186-190.
8. Saab CY, Craner MJ, Kataoka Y, Waxman SG. Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis. Exp Brain Res 2004;158:1-8.
9. V1.8 sodium channels perturbs the firing patterns of cerebellar Purkinje cells. Brain Res 2003;959:235.
10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
12. Eshaghi A, Riyahi-Alam S, Roostaei T, et al. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). Clin Neuropsychol 2012;26:975-984.
13. Schmitz-Hübsch T, Du Montcel ST, Baliko L, et al. Scale for the Assessment and Rating of Ataxia: development of a new clinical scale. Neurology 2006;66:1717-1720.
14. van den Boogaard M, Wong LYE, Tessadori F, et al. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J Clin Invest 2012;122:2519-2530.
15. Jabbari J, Olesen MS, Yuan L, et al. Common and rare variants in SCN10A modulate the risk of atrial fibrillation. Circ Cardiovasc Genet 2014;8:64-73.
16. Konopac M, Dusatkova P, Cinek O. SNPman: a program for genotype calling using run data from TaqMan allelic discrimination. Bioinformatics 2011;27:2306-2308.
17. Sahraian A, Radü EW. MRI Atlas of MS Lesions, 1st ed. Berlin: Springer-Verlag; 2008.
18. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage 2000;11:805-821.
19. Chakravarty MM, Steadman P, Eede MC, et al. Performing label fusion based segmentation using multiple automatically generated templates. Hum Brain Mapp 2013;34:2635-2654.
20. Park MTM, Pipitone J, Baer LH, et al. Derivation of high-resolution MRI atlases of the human cerebellum at 3T and segmentation using multiple automatically generated templates. Neuroimage 2014;95:217-231.
21. Filippini N, MacIntosh BJ, Hough MG, et al. Distinct patterns of brain activity in young carriers of the APOE-ε 4 allele. Proc Natl Acad Sci USA 2009;106:7209-7214.
22. Diedrichsen J, Balsters JH, Flavell J, Cussans E, Ramnani N. A probabilistic MR atlas of the human cerebellum. Neuroimage 2009;46:39-46.
23. Roostaei T, Sadaghiani S, Park MTM, et al. Central cerebellar white matter contributes to motor coordination deficits in multiple sclerosis. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); Copenhagen; 2013.
24. Bezzina CR, Barc J, Mizusawa Y, et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 2013;45:1044-1049.
25. Smith JG, Magnani JW, Palmer C, et al. Genome-wide association studies of the PR interval in African Americans. PLoS Genetics 2011;7:e1001304.
26. Roostaei T, Nazeri A, Sahraian MA, Minagar A. The human cerebellum: a review of Physiologic Neuroanatomy. Neurol Clin 2014;32:859-869.
27. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler 1999;5:244-250.
28. Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron 2013;80:807-815.
29. V1.8 sodium channels to action potential electrogenesis in DRG neurons. J Neurophysiol 2001;86:629-640.
30. V1.8: enhanced persistent and ramp currents contribute to distinct firing properties of human DRG neurons. J Neurophysiol 2015;113:3172-3185.
31. Shmuel A, Leopold DA. Neuronal correlates of spontaneous fluctuations in fMRI signals in monkey visual cortex: implications for functional connectivity at rest. Hum Brain Mapp 2008;29:751-761.
32. Richiardi J, Altmann A, Milazzo A-C, et al. Correlated gene expression supports synchronous activity in brain networks. Science 2015;348:1241-1244.
33. Cerasa A, Passamonti L, Valentino P, et al. Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs. Exp Neurol 2012;237:418-426.
34. Tona F, Petsas N, Sbardella E, et al. Multiple sclerosis: altered thalamic resting-state functional connectivity and its effect on cognitive function. Radiology 2014;271:814-821.
35. Rocca MA, Bonnet MC, Meani A, et al. Differential cerebellar functional interactions during an interference task across multiple sclerosis phenotypes. Radiology 2012;265:864-873.
36. Schattling B, Eggert B, Friese MA. Acquired channelopathies as contributors to development and progression of multiple sclerosis. Exp Neurol 2014;262:28-36.
37. Iorio R, Capone F, Plantone D, Batocchi AP. Paroxysmal ataxia and dysarthria in multiple sclerosis. J Clin Neurosci 2014;21:174-175.
38. Blanco Y, Compta Y, Graus F, Saiz A. Midbrain lesions and paroxysmal dysarthria in multiple sclerosis. Mult Scler 2008;14:694-697.
39. V1.8 blocker, reverses cerebellar deficits in a mouse model of multiple sclerosis. PLoS One 2015;10:e0119067.